Veracyte (VCYT) Competitor Comparison
We are evaluating the key criteria listed to compare Veracyte (VCYT) against its competitors in the Biotechnology industry.
Market Capitalization
90 / 368Gross Profits
31 / 278Total Revenue
34 / 300EBITDA
29 / 337Free Cashflow
21 / 352Quick Ratio
207 / 357Earnings per Share
50 / 359Dividend yield
0 / 6Total Cash
154 / 358Performance 3 years
118 / 368Performance 5 years
95 / 368Performance 10 years
20 / 368Linearity 3 years
58 / 368Linearity 5 years
112 / 368Linearity 10 years
349 / 368Total Rank
53 / 368Dividend Rank
299 / 368Valuation Rank
15 / 368Piotroski Rank
70 / 368Muliplier Rank
226 / 368EBITDA - VCYT ranking 29 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.